Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neovascular Age-related Macular Degeneration (AMD)”

640 trials

Showing 20 of 640 results

Large-scale testing (Phase 3)Active Not RecruitingNCT06223958
What this trial is testing

Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Ocular Therapeutix) (Axitinib Implant) in Subjects With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration
Ocular Therapeutix, Inc. 344
Not applicableStudy completedNCT05202587
What this trial is testing

The Evaluation of the Agreement Between the NVHO in the Automatic Fluid Quantification and Cirrus OCT

Who this might be right for
Neovascular Age-related Macular Degeneration
Notal Vision Inc. 386
Testing effectiveness (Phase 2)Study completedNCT04820452
What this trial is testing

IBI302 in Patients With nAMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Innovent Biologics (Suzhou) Co. Ltd. 231
Post-approval studies (Phase 4)Active Not RecruitingNCT06795048
What this trial is testing

Determine the Efficacy, Safety, and Durability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD)
Hoffmann-La Roche 274
Testing effectiveness (Phase 2)Study completedNCT02732899
What this trial is testing

Sirolimus in Conjunction With Eylea vs Eylea Alone for Exudative AMD

Who this might be right for
Exudative Age Related Macular Degeneration
Maturi, Raj K., M.D., P.C. 20
Large-scale testing (Phase 3)Active Not RecruitingNCT06864988
What this trial is testing

4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

Who this might be right for
Macular Neovascularization Secondary to Age-Related Macular Degeneration
4D Molecular Therapeutics 480
Testing effectiveness (Phase 2)Study completedNCT00043680
What this trial is testing

Celecoxib to Treat Macular Degeneration in Patients Receiving Photodynamic Therapy

Who this might be right for
Macular Degeneration
National Eye Institute (NEI) 60
Testing effectiveness (Phase 2)Ended earlyNCT00857259
What this trial is testing

The Efficacy of Oral Everolimus in Patients With Neovascular Age-related Macular Degeneration

Who this might be right for
Choroidal Neo-Vascular Age-onset Macular DegenerationAge-related Macular Degeneration
Novartis Pharmaceuticals 16
Post-approval studies (Phase 4)Study completedNCT02125864
What this trial is testing

Plasma Levels of Vascular Endothelial Growth Factor Before and After Intravitreal Injection of Aflibercept

Who this might be right for
Exudative Age-related Macular Degeneration
Oslo University Hospital 16
Large-scale testing (Phase 3)Study completedNCT03805100
What this trial is testing

Comparing the Efficacy and Safety of Biosimilar Candidate Xlucane Versus Lucentis® in Patients With nAMD

Who this might be right for
Macular Degeneration
Xbrane Biopharma AB 582
Testing effectiveness (Phase 2)Ended earlyNCT01624636
What this trial is testing

Safety and Tolerability of Intravenous LFG316 in Wet Age-related Macular Degeneration (AMD).

Who this might be right for
Neovascular Age-related Macular Degeneration
Novartis Pharmaceuticals 1
Post-approval studies (Phase 4)UnknownNCT03918590
What this trial is testing

Post Intravitreal Injection Topical NSAID vs. Patching

Who this might be right for
Neovascular Age-related Macular DegenerationDiabetic Macular EdemaRetinal Vein Occlusion
The New York Eye & Ear Infirmary 60
Post-approval studies (Phase 4)Study completedNCT02309281
What this trial is testing

Intravitreal Aflibercept in Neovascular AMD With Limited Response to Ranibizumab

Who this might be right for
Neovascular Age-related Macular Degeneration
Vista Klinik 33
Large-scale testing (Phase 3)UnknownNCT00788177
What this trial is testing

Subretinal Macugen® for Neovascular Age-Related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Klinikum Ludwigshafen 10
Very early researchNot Yet RecruitingNCT07728981
What this trial is testing

Biomarkers, Effectiveness, and Safety of Aflibercept 8mg Modified Fixed Dose Regimen in Treatment-Naïve nAMD Patients

Who this might be right for
Neovascular Age-Related Macular Degeneration (nAMD) Wet AMD
Tianjin Medical University Eye Hospital 49
Testing effectiveness (Phase 2)UnknownNCT05380492
What this trial is testing

Study of VOY-101 in Patients With Advanced Non-Neovascular Age-Related Macular Degeneration

Who this might be right for
Age-related Macular DegenerationGeographic Atrophy
Perceive Biotherapeutics, Inc. 45
Not applicableStudy completedNCT03712670
What this trial is testing

Nutraceutical Support With Omega-3

Who this might be right for
Retinal Disease
Università degli Studi di Brescia 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07607561
What this trial is testing

Phase 2a Study to Evaluate the Efficacy and Safety of SCAI-005 Ophthalmic Solution in Subjects With Neovascular Age-related Macular Degeneration

Who this might be right for
wetAMDAge Related Macular Degeneration
SCAI Therapeutics 50
Large-scale testing (Phase 3)Looking for participantsNCT07317934
What this trial is testing

Efficacy and Safety of LX102 Gene Therapy in Patients With Neovascular Age-related Macular Degeneration (nAMD) (STELLAR)

Who this might be right for
Neovascular Age-Related Macular Degeneration (nAMD)Wet AMD
Innostellar Biotherapeutics Co.,Ltd 388
Early research (Phase 1)Study completedNCT03835884
What this trial is testing

A Study Assessing AR-13503 Implant in Subjects With nAMD or DME

Who this might be right for
Neovascular Age-related Macular DegenerationDiabetic Macular Edema
Aerie Pharmaceuticals 18
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation